InNexus Biotechnology Top Insiders
| IXSBFDelisted Stock | USD 0.0001 0.00 0.00% |
InNexus Biotechnology employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of InNexus Biotechnology's management performance can provide insight into the company performance.
InNexus |
InNexus Biotechnology Management Team Effectiveness
The company has return on total asset (ROA) of (0.3074) % which means that it has lost $0.3074 on every $100 spent on assets. This is way below average. InNexus Biotechnology's management efficiency ratios could be used to measure how well InNexus Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.InNexus Biotechnology Workforce Comparison
InNexus Biotechnology is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 97.0. InNexus Biotechnology holds roughly 2.0 in number of employees claiming about 2.06% of equities under Health Care industry.
InNexus Biotechnology Notable Stakeholders
An InNexus Biotechnology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as InNexus Biotechnology often face trade-offs trying to please all of them. InNexus Biotechnology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting InNexus Biotechnology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jur Strobos | Vice Board | Profile | |
| Angela Giannoccaro | Chief Officer | Profile |
About InNexus Biotechnology Management Performance
The success or failure of an entity such as InNexus Biotechnology often depends on how effective the management is. InNexus Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of InNexus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the InNexus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
InNexus Biotechnology, Inc., a development stage company, engages in the commercialization of monoclonal antibodies based on its Dynamic Cross Linking technology. InNexus Biotechnology, Inc. is headquartered in Vancouver, Canada. Innexus Biotechnology is traded on OTC Exchange in the United States.
InNexus Biotechnology Workforce Analysis
Traditionally, organizations such as InNexus Biotechnology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare InNexus Biotechnology within its industry.InNexus Biotechnology Manpower Efficiency
Return on InNexus Biotechnology Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 3.3M | |
| Net Loss Per Executive | 3.3M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in InNexus Stock
If you are still planning to invest in InNexus Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InNexus Biotechnology's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |